Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
03 nov. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American...
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
01 nov. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait
13 oct. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) -- National Physical Therapy Month (NPTM) comes every October, but this one is particularly meaningful to Helius Medical Technologies (NASDAQ: HSDT):...
Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference
29 sept. 2022 17h20 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
14 sept. 2022 17h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September
06 sept. 2022 06h30 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results
15 août 2022 16h05 HE
|
Helius Medical Technologies, Inc.
-- Net proceeds from August 2022 financing and cash on hand expected to fund operations through 2023 ---- Company to host call at 4:30pm today -- NEWTOWN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) --...
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022
10 août 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering
05 août 2022 08h38 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
12 juil. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., July 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...